RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China SXT Pharmaceuticals Stock

China SXT Pharmaceuticals Debt 2024

China SXT Pharmaceuticals Debt

-9.66 USD

Ticker

SXTC

ISIN

VGG2161P1163

In 2024, China SXT Pharmaceuticals's total debt was -9.66 USD, a -28.29% change from the -13.47 USD total debt recorded in the previous year.

China SXT Pharmaceuticals Aktienanalyse

What does China SXT Pharmaceuticals do?

China SXT Pharmaceuticals Inc is a Chinese company specializing in the development, manufacturing, and marketing of traditional Chinese medicines (TCM). It was founded in 2005 and is headquartered in Taizhou City, Jiangsu Province. The company is publicly listed on the Nasdaq. The company was founded in 2005 by Dr. Feng Zhou and other experts in the field of TCM. It quickly grew and established itself successfully in the market, becoming one of the leading companies in the TCM industry in China. China SXT Pharmaceuticals Inc's business model is based on the development, manufacturing, and marketing of TCM products. The company has an extensive portfolio of products based on traditional Chinese remedies. It combines traditional and modern methods of medicine and constantly strives to improve the quality of its products. The company is divided into three business segments. The first segment focuses on the TCM industry, where the company develops and manufactures its products and operates a research and development department. The second segment is regular pharmacies, where brand awareness is increased and products are marketed through distribution efforts. The third segment is online sales, where customers can order products directly through various platforms. The company offers a wide range of products based on traditional Chinese remedies. The product range includes treatments for various diseases, including cancer and viral diseases. Many products in the range are patented and exclusively available from China SXT Pharmaceuticals Inc. One of the most well-known product lines is the "Shenqi" range, used for the treatment of kidney diseases and high blood pressure. In recent years, the company has focused on expanding internationally and aims to increase its presence in the global market. It has made several acquisitions and acquisitions both domestically and internationally to expand its portfolio and strengthen its presence in the global market. China SXT Pharmaceuticals Inc has over 200 registered products in China and operates in over 30 countries. It is one of the top 20 companies in the Chinese TCM industry and has built a solid reputation through its expertise in TCM over the years. In summary, China SXT Pharmaceuticals Inc is an innovative and emerging company in traditional medicine. It aims to strengthen its presence in the global market and take a leading role in the development and manufacturing of TCM products. With its wide product range, high quality, and focus on innovation and progress, it is one of the most promising companies in the TCM industry in China. China SXT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding China SXT Pharmaceuticals's Debt Structure

China SXT Pharmaceuticals's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing China SXT Pharmaceuticals's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to China SXT Pharmaceuticals’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in China SXT Pharmaceuticals’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about China SXT Pharmaceuticals stock

What is the debt of China SXT Pharmaceuticals this year?

China SXT Pharmaceuticals has a debt level of -9.66 USD this year.

What was the debt of China SXT Pharmaceuticals compared to the previous year?

The debt of China SXT Pharmaceuticals has increased by -28.29% compared to the previous year dropped.

What are the consequences of high debt for investors in China SXT Pharmaceuticals?

High debt can pose a risk for investors of China SXT Pharmaceuticals, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of China SXT Pharmaceuticals?

Low debt means that China SXT Pharmaceuticals has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from China SXT Pharmaceuticals affect the company?

An increase in debt of China SXT Pharmaceuticals can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of China SXT Pharmaceuticals affect the company?

A reduction in debt of China SXT Pharmaceuticals can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of China SXT Pharmaceuticals?

Some factors that can influence the debt of China SXT Pharmaceuticals include investments, acquisitions, operating costs, and revenue development.

Why are the debts of China SXT Pharmaceuticals so important for investors?

The debts of China SXT Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can China SXT Pharmaceuticals take to change the debt?

To change the debt, China SXT Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does China SXT Pharmaceuticals pay?

Over the past 12 months, China SXT Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, China SXT Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of China SXT Pharmaceuticals?

The current dividend yield of China SXT Pharmaceuticals is .

When does China SXT Pharmaceuticals pay dividends?

China SXT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of China SXT Pharmaceuticals?

China SXT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of China SXT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is China SXT Pharmaceuticals located?

China SXT Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von China SXT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China SXT Pharmaceuticals from 10/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/19/2024.

When did China SXT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/19/2024.

What was the dividend of China SXT Pharmaceuticals in the year 2023?

In the year 2023, China SXT Pharmaceuticals distributed 0 USD as dividends.

In which currency does China SXT Pharmaceuticals pay out the dividend?

The dividends of China SXT Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China SXT Pharmaceuticals

Our stock analysis for China SXT Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China SXT Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.